Literature DB >> 7230765

Resident research award. Effects of cholecystokinin on gallbladder stasis and cholesterol gallstone formation.

J J Roslyn, L DenBesten, H A Pitt, S Kuchenbecker, J W Polarek.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7230765     DOI: 10.1016/0022-4804(81)90148-7

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


× No keyword cloud information.
  9 in total

Review 1.  Complications of long-term home total parenteral nutrition: their identification, prevention and treatment.

Authors:  A L Buchman
Journal:  Dig Dis Sci       Date:  2001-01       Impact factor: 3.199

Review 2.  Biliary motility.

Authors:  P A Grace; G J Poston; R C Williamson
Journal:  Gut       Date:  1990-05       Impact factor: 23.059

Review 3.  Gall stones and gall bladder motility.

Authors:  L J O'Donnell; P D Fairclough
Journal:  Gut       Date:  1993-04       Impact factor: 23.059

4.  Chronic acalculous gallbladder disease: a clinical enigma.

Authors:  P F Nora; R P Davis; M J Fernandez
Journal:  World J Surg       Date:  1984-02       Impact factor: 3.352

5.  Altered migrating myoelectrical complex in an animal model of cholesterol gallstone disease: the effect of erythromycin.

Authors:  Q W Xu; R B Scott; D T Tan; E A Shaffer
Journal:  Gut       Date:  1998-12       Impact factor: 23.059

6.  [Experimental gallstone formation. Etiological significance of beta-glucuronidase producing bacteria and biliary obstruction].

Authors:  E Hancke; G Marklein
Journal:  Langenbecks Arch Chir       Date:  1983

Review 7.  Gallbladder motility, gallstones, and the surgeon.

Authors:  R Patankar; M M Ozmen; I S Bailey; C D Johnson
Journal:  Dig Dis Sci       Date:  1995-11       Impact factor: 3.199

8.  Early stages of gallstone formation in guinea pig are associated with decreased biliary sensitivity to cholecystokinin.

Authors:  G J Poston; P Singh; E Draviam; C Z Yao; G Gomez; J C Thompson
Journal:  Dig Dis Sci       Date:  1992-08       Impact factor: 3.199

9.  Cholecystokinin prophylaxis of parenteral nutrition-induced gallbladder disease.

Authors:  J E Doty; H A Pitt; V Porter-Fink; L Denbesten
Journal:  Ann Surg       Date:  1985-01       Impact factor: 12.969

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.